WA
SCMP

Whitebox Advisors’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Whitebox Advisors’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-66,337
Closed -$1.15M – 159
2015
Q4 		$1.15M Sell
66,337
-97,345
-59% -$1.75M 0.03% 153
2015
Q3 		$3.25M Sell
163,682
-29,288
-15% -$671K 0.15% 134
2015
Q2 		$3.17M Buy
+192,970
New +$3.35M 0.14% 153

Other funds holding SCMP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Whitebox Advisors's SCMP Position: Q1 2016 in Review

Whitebox Advisors sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2016, closing a stake of 66,337 shares — an estimated $1.15M sold.

Whitebox Advisors first reported a position in SCMP in Q2 2015 and held it in 3 quarters. The position peaked at $3.25M in Q3 2015. 134 funds tracked by Wall St. Rank hold SCMP as of Q1 2016.

  • Whitebox Advisors reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
  • Whitebox Advisors sold 66,337 Sucampo Pharmaceuticals, Inc. shares in Q1 2016, an estimated $1.15M.
  • Whitebox Advisors first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2015 and held it in 3 quarters.
  • Whitebox Advisors's Sucampo Pharmaceuticals, Inc. position peaked at $3.25M in Q3 2015.
  • 134 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2016.

Based on Whitebox Advisors's 13F filing for Q1 2016, filed 3 May 2016.